Adverse drug reactions associated with ivermectin use for COVID-19 reported in the World Health Organization's pharmacovigilance database

Jérémy Campillo; Jean-Luc Faillie

doi:10.1016/j.therap.2022.03.002

Back

Adverse drug reactions associated with ivermectin use for COVID-19 reported in the World Health Organization's pharmacovigilance database

Journal article

Open access

Peer reviewed

Adverse drug reactions associated with ivermectin use for COVID-19 reported in the World Health Organization's pharmacovigilance database

Jérémy Campillo and Jean-Luc Faillie

Therapies, Vol.77(6), pp.747-749

11/2022

DOI: https://doi.org/10.1016/j.therap.2022.03.002

PMCID: PMC9020491

PMID: 35606189

Abstract

COVID-19

Ivermectin

Pharmacovigilance

Since the onset of the coronavirus disease 2019 (COVID19) pandemic, numerous drugs have been proposed for the management of the infection. Among them, ivermectin has been the subject of many scientific studies evaluating its potential antiviral efficacy. Despite the fact that it has never been proven that ivermectin can be effective in the management of COVID-19.

Files and links (2)

url

Find in HALView

url

https://doi.org/10.1016/j.therap.2022.03.002View

Published (Version of record) Open

Metrics

1 Record Views

Details

Title: Adverse drug reactions associated with ivermectin use for COVID-19 reported in the World Health Organization's pharmacovigilance database
Creators - without role: Jérémy Campillo - Recherches Translationnelles sur le VIH et les Maladies Infectieuses
Jean-Luc Faillie - Université de Montpellier, Institut Desbrest d Epidemiologie et de Sante Publique - IDESP
Publication Details: Therapies, Vol.77(6), pp.747-749
Identifiers: 9939852809311
Academic Unit: Institut Desbrest d Epidemiologie et de Sante Publique - IDESP; Recherches translationnelles sur le VIH et les Maladies Infect. Endém. émerg. - TransVIHMI
Language: English
Resource Type: Journal article
Local Fields: hal-04155828